The Korean Journal of Medicine

  • 제99권1호
  • /
  • Pages.4-10
  • /
  • 2024
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

악성 간문부 담도 폐쇄에서 내시경 배액술의 최근 경향

Trends of Endoscopic Palliation for Advanced Malignant Hilar Biliary Obstruction

  • 이태훈 (순천향대학교 의과대학 순천향대학교 부속 천안병원 소화기내과)
  • Tae Hoon Lee (Division of Gastroenterology & Hepatology, Department of Internal Medicine, SoonChunHyang University Cheonan Hospital, SoonChunHyang University College of Medicine)
  • 투고 : 2023.11.22
  • 심사 : 2023.12.11
  • 발행 : 2024.02.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Malignant hilar biliary obstruction (MHO), an aggressive type of perihilar biliary obstruction caused by cholangiocarcinoma, gallbladder cancer, or other metastatic malignancies, has a poor prognosis. Surgical resection is the only curative treatment for biliary malignancies. However, most patients with MHO cannot undergo surgery upon presentation because of their advanced inoperable state or poor performance resulting from old age or comorbid diseases. Therefore, palliative biliary drainage is required to improve symptomatic jaundice and quality of life. Preoperative biliary drainage is controversial in resectable cases of MHO. Preoperative biliary drainage should be considered according to specific selection criteria. Palliative drainage is currently the mainstay of symptomatic treatment. Compared with percutaneous access, primary endoscopic palliation using plastic or metal stents has recently shown higher technical feasibility and clinical success without increasing the frequency of adverse events, even in high-degree MHO. However, the use of stents still has numerous limitations, including challenges in determining the optimal type of stent, number of stents, deployment method, and additional local therapies. Therefore, this report presents the current optimal endoscopic drainage status for MHO based on recent guidelines and published literature.

키워드

참고문헌

  1. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-517; discussion 517-519.
  2. Lee TH. Technical tips and issues of biliary stenting, focusing on malignant hilar obstruction. Clin Endosc 2013;46:260-266. https://doi.org/10.5946/ce.2013.46.3.260
  3. Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988;12:39-47. https://doi.org/10.1007/BF01658484
  4. Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol 2013;28:593-607. https://doi.org/10.1111/jgh.12128
  5. Meybodi MA, Shakoor D, Nanavati J, et al. Unilateral versus bilateral endoscopic stenting in patients with unresectable malignant hilar obstruction: a systematic review and meta-analysis. Endosc Int Open 2020;8:E281-E290. https://doi.org/10.1055/a-1067-4326
  6. Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015;17:691-699. https://doi.org/10.1111/hpb.12450
  7. Olthof PB, Wiggers JK, Koerkamp BG, et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J Am Coll Surg 2017;225:387-394. https://doi.org/10.1016/j.jamcollsurg.2017.06.007
  8. Chen GF, Yu WD, Wang JR, Qi FZ, Qiu YD. The methods of preoperative biliary drainage for resectable hilar cholangiocarcinoma patients: a protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e20237.
  9. Qumseya BJ, Jamil LH, Elmunzer BJ, et al. ASGE guideline on the role of endoscopy in the management of malignant hilar obstruction. Gastrointest Endosc 2021;94:222-234.e22. https://doi.org/10.1016/j.gie.2020.12.035
  10. Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline - updated October 2017. Endoscopy 2018;50:910-930. https://doi.org/10.1055/a-0659-9864
  11. Moole H, Dharmapuri S, Duvvuri A, et al. Endoscopic versus percutaneous biliary drainage in palliation of advanced malignant hilar obstruction: a meta-analysis and systematic review. Can J Gastroenterol Hepatol 2016;2016:4726078.
  12. Lee TH, Moon JH, Park SH. Biliary stenting for hilar malignant biliary obstruction. Dig Endosc 2020;32:275-286. https://doi.org/10.1111/den.13549
  13. Elmunzer BJ, Maranki JL, Gomez V, et al. ACG clinical guideline: diagnosis and management of biliary strictures. Am J Gastroenterol 2023;118:405-426. https://doi.org/10.14309/ajg.0000000000002190
  14. Raijman I. Biliary and pancreatic stents. Gastrointest Endosc Clin N Am 2003;13:561-592, vii-viii. https://doi.org/10.1016/S1052-5157(03)00069-2
  15. Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003;57:178-182. https://doi.org/10.1067/mge.2003.66
  16. Shim SR, Lee TH, Yang JK, et al. Endoscopic bilateral stent-in-stent versus stent-by-stent deployment in advanced malignant hilar obstruction: a meta-analysis and systematic review. Dig Dis Sci 2022;67:716-728. https://doi.org/10.1007/s10620-021-06885-8
  17. Cosgrove N, Siddiqui AA, Adler DG, et al. A comparison of bilateral side-by-side metal stents deployed above and across the sphincter of oddi in the management of malignant hilar biliary obstruction. J Clin Gastroenterol 2017;51:528-533. https://doi.org/10.1097/MCG.0000000000000584
  18. Lee TH, Choi JH, Park DH, et al. Similar efficacies of endoscopic ultrasound-guided transmural and percutaneous drainage for malignant distal biliary obstruction. Clin Gastroenterol Hepatol 2016;14:1011-1019.e3. https://doi.org/10.1016/j.cgh.2015.12.032
  19. Paik WH, Lee TH, Park DH, et al. EUS-guided biliary drainage versus ERCP for the primary palliation of malignant biliary obstruction: a multicenter randomized clinical trial. Am J Gastroenterol 2018;113:987-997. https://doi.org/10.1038/s41395-018-0122-8
  20. Nakai Y, Kogure H, Isayama H, Koike K. Endoscopic ultrasound-guided biliary drainage for unresectable hilar malignant biliary obstruction. Clin Endosc 2019;52:220-225. https://doi.org/10.5946/ce.2018.094
  21. van der Merwe SW, van Wanrooij RLJ, Bronswijk M, et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2022;54:185-205. https://doi.org/10.1055/a-1717-1391
  22. Cheon YK, Lee TY, Lee SM, Yoon JY, Shim CS. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford) 2012;14:185-193. https://doi.org/10.1111/j.1477-2574.2011.00424.x
  23. Inoue T, Ibusuki M, Kitano R, et al. Endobiliary radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstruction. Endoscopy 2020;52:595-599. https://doi.org/10.1055/a-1133-4448
  24. Kang H, Han SY, Cho JH, et al. Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: a pilot multicenter randomized comparative trial. J Hepatobiliary Pancreat Sci 2022;29:469-478. https://doi.org/10.1002/jhbp.1082